D. E. Shaw & Co »

Centessa Pharmaceuticals shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $769k 48k 15.99
2021-09-30 $207k 12k 16.67

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon (AMZN)
Tesla Motors Put Option (TSLA)
Netflix Put Option (NFLX)
Booking Holdings Call Option (BKNG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Eli Lilly & Co. Call Option (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation (BAC)
Palantir Technologies Cl A (PLTR)
Citigroup Com New Put Option (C)

View all positions for D. E. Shaw & Co

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
General Atlantic
Perceptive Advisors
First Light Asset Management
EcoR1 Capital
T. Rowe Price Associates
Vida Ventures Advisors
T. Rowe Price Investment Management
Siren
TCG Crossover Management
Point72 Asset Management
Franklin Resources
Driehaus Capital Management
Avidity Partners Management
Morgan Stanley

View all funds holding Centessa Pharmaceuticals